News Burma Politics War Against the Junta Myanmar’s Crisis & the World Conflicts In Numbers Junta Crony Ethnic Issues Asia World Business Business Roundup Economy Money Election 2020 Elections in History Election 2015

Opinion Editorial Commentary Guest Column Analysis Letters Cartoons Features In Person Interview Profile Dateline

Specials Myanmar Diary Women & Gender Places in History On This Day From the Archive Myanmar & COVID-19 Intelligence Myanmar-China Watch Culture Arts Heritage Books

Lifestyle Travel Food Fashion & Design Videos Photos Photo Essays Constitution Contact Careers Burmese Version Donate

Asia

Fujifilm May Seek Approval for COVID-19 Drug Next Month

Supplied photo shows tablets of the anti-influenza drug Avigan. / Fujifilm / Kyodo

5.2k

By Kyodo News 24 September 2020

TOKYO—Fujifilm Holdings Corp. said Wednesday it will seek regulatory approval as early as October for the use of its antivirus drug Avigan to treat patients infected with the coronavirus, as clinical tests have shown efficacy in easing symptoms.

According to analysis of data on 156 patients without severe symptoms, Fujifilm found those administered with Avigan show improvement after 11.9 days, shorter than the 14.7 days for those in a placebo group.

Read more.

You may also like these stories:

Japan to Ease COVID-19 Entry Ban to Allow Long-Term Stays

India’s Taj Mahal Reopens to Visitors After More Than Six Months

Legendary Sherpa, 1st to Conquer Everest 10 Times, Dies at 72

Topics: Japan

Your Thoughts …

Loading

Loading

We do not encourage viewing this site in this width. Please increase the size of your window.